The Question and Answer document contains 48 questions and will be updated regularly to address new developments and issues.
The questions are divided into the following subject areas:
- Concept for licensing similar biotherapeutic products
- Reference biotherapeutic products
- Quality
- Nonclinical evaluation
- Clinical evaluation
- Pharmacovigilance
Source:
WHO